Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer
-
* Corresponding author: Sherene Loi sherene.loi@bordet.be
BMC Medical Genomics 2009, 2:37 doi:10.1186/1755-8794-2-37
Accesses
- Last 30 days: 59 accesses
- Last 365 days: 818 accesses
- All time: 5084 accesses
Cited by
BioMed Central: 3 citations
|
Luminal-B breast cancer and novel therapeutic targets Ben Tran, Philippe L Bedard Breast Cancer Research 2011, 13:221 (30 November 2011) |
|
Kevin Morgan, Colette Meyer, Nicola Miller, Andrew H Sims, Ilgin Cagnan, Dana Faratian, David J Harrison, Robert P Millar, Simon P Langdon BMC Cancer 2011, 11:476 (3 November 2011) |
|
Karen J Taylor, Andrew H Sims, Liang Liang, Dana Faratian, Morwenna Muir, Graeme Walker, Barbara Kuske, J Michael Dixon, David A Cameron, David J Harrison, Simon P Langdon Breast Cancer Research 2010, 12:R39 (22 June 2010) |